PCVX vs LEGN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
LEGN Captures Institutional Edge (2โ2 Pillars ยท 5โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Legend Biotech Corporation American Depositary Shares (LEGN) driven by superior Valuation, Growth & Margin while PCVX counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, PCVX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus LEGN at 27.5x Forward P/E and 2.8% operating margin (+32.0% YoY). In options structure, PCVX sits in CONSOLIDATION (10th %ile IV; Dealer Gamma Walls on Pro) against LEGN sits in UNCLASSIFIED (24th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PCVX | LEGN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $10.2B | $3.6B | Larger Scale | PCVX |
| Trailing P/E Ratio Valuation | N/M | 23.0x | Lower Multiple | LEGN |
| Forward P/E Ratio Valuation | N/M | 27.5x | Lower Multiple | LEGN |
| Revenue Growth (YoY) Growth | +0.0% | +32.0% | Higher Growth | LEGN |
| Operating Margin (TTM) Profitability | 0.0% | 2.8% | Higher Margin | LEGN |
| Net Profit Margin Profitability | 0.0% | -0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -42.7% | -0.0% | Higher ROE | LEGN |
| 52-Week Range Position Momentum | 41% ($42โ$91) | 0% ($16โ$38) | Stronger Trend | PCVX |
| Beta / 30D Volatility Risk Regime | 1.29ฮฒ ยท 57% Vol | 1.02ฮฒ ยท 83% Vol | Lower Realized Risk | PCVX |
| Unified Institutional Score Composite Signal | 47.3 / 100 (HOLD) | 42.8 / 100 (HOLD) | Higher Composite | PCVX |